Citations 1
Decreased copy number aberrations in genomes of HER2+ metastatic breast cancer (MBC) patients (pts) with extraordinary durable complete responses (dCR) to trastuzumab (T).
Maguire, Alanna , Gullo, Giuseppe , Quinn, Cecily , Malasi, Smriti, Lenkiewicz, Elizabeth, Barrett, Michael T. , O’Donovan, Norma , Walsh, Naomi , Crown, John
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 610-610
